Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis

Samuel Raimundo Fernandes1, Patrícia Santos2, Narcisa Fatela2

  • 1Serviço de Gastrenterologia e Hepatologia, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisboa, Portugal. Samuelrmfernandes@gmail.com.

Abstract

Insights

A new point-of-care test for ascitic calprotectin accurately diagnoses spontaneous bacterial peritonitis (SBP) in cirrhosis patients. This reliable method offers a promising alternative to conventional diagnostic approaches for SBP.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Clinical Diagnostics

Background:

  • Spontaneous bacterial peritonitis (SBP) is a severe complication of advanced cirrhosis with high mortality.
  • Diagnosis relies on ascitic fluid polymorphonuclear (PMN) cell count >250/μl, the current gold standard.
  • There is a need for rapid and accurate diagnostic methods for SBP.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of a point-of-care test (POCT) for ascitic calprotectin in patients with SBP.
  • To compare the efficacy of ascitic calprotectin POCT with the traditional PMN cell count method.

Main Methods:

  • Eighty-eight patients with decompensated liver cirrhosis were studied.
  • Ascitic calprotectin was measured using a quantitative POCT.
  • Patients were categorized based on the presence or absence of SBP.

Main Results:

  • Ascitic calprotectin levels were significantly higher in SBP patients and correlated with PMN counts.
  • An optimal calprotectin cutoff of 1.57 μg/ml showed high sensitivity (87.8%) and specificity (97.9%).
  • Using calprotectin in patients with a serum albumin-ascites gradient >11 g/l enhanced diagnostic values.

Conclusions:

  • Ascitic calprotectin POCT is a reliable method for diagnosing SBP in liver cirrhosis patients.
  • This test offers a potential alternative to conventional diagnostic methods.
  • The POCT provides rapid and accurate results for SBP diagnosis.

Related Concept Videos